Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisHematologic NeoplasmsAntigens, CD34Blood Component RemovalMultiple MyelomaStem Cell TransplantationBone Marrow TransplantationCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeMyeloablative AgonistsBusulfanGraft vs Host DiseaseGraft SurvivalLymphoma, Non-HodgkinRecurrenceEtoposideHematopoietic Stem CellsRadiation DosageThiotepaAntineoplastic Agents, AlkylatingRemission InductionHodgkin DiseaseCarmustineDose-Response Relationship, RadiationCytophagocytosisIfosfamideSalvage TherapyVincristineRetrospective StudiesAmyloidosisCytarabineStem CellsHematopoiesisDisease-Free SurvivalCord Blood Stem Cell TransplantationSurvival AnalysisTissue DonorsTransplantation ChimeraNeoplasmsSurvival RateRadiation InjuriesWhole-Body IrradiationTime FactorsGamma RaysInfectionLymphoma, T-CellDoxorubicinImmunosuppressive AgentsHistocompatibilityPlatelet CountPOEMS SyndromeHistocompatibility TestingPrednisoneCarboplatinTransplantation, IsogeneicLeukemia, Myeloid, AcuteFollow-Up StudiesDexamethasoneVidarabineBlood Cell CountRecombinant ProteinsLeukemiaBone Marrow PurgingAntineoplastic AgentsCytomegalovirus InfectionsProspective StudiesBlood Transfusion, AutologousLymphomaBlood CellsFatal OutcomeFeasibility StudiesGraft vs Leukemia EffectMyelodysplastic SyndromesImmunophenotypingKidney TransplantationAnemia, AplasticT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionCyclosporineLiver TransplantationLeukocytes, MononuclearOpportunistic InfectionsImmunosuppressionHLA AntigensPrognosisBone MarrowHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaHistiocytosis, Non-Langerhans-Cell